Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Auditory Control Enhancement (ACE) in Schizophrenia [NA]
A clinical trial studying Auditory Control Enhancement (ACE) for auditory hallucinations in schizophrenia was terminated and results were po…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Synbiotic Compound to Reduce Symptoms of Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating a synbiotic compound to reduce symptoms of schizophrenia and schizoaffective disorder is currently recru…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Acetazolamide for Treatment Resistant Schizophrenia [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial is evaluating acetazolamide for treatment-resistant schizophrenia, with recruitment currently ongoing.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder [Phase 2]
Phase 2 clinical trial assessing measures of acute psychomotor agitation in people with schizophrenia and bipolar disorder has completed. Th…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizophrenia [NA]
Completed clinical trial assessing the acceptability and potential efficacy of a group reminiscence intervention for adults with schizophren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia [Phase 3]
Phase 3 trial update showing Evenamide as an add-on to standard of care for schizophrenia in people with treatment-resistant schizophrenia; …
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component [Phase 2]
This Phase 2 trial evaluating repetitive transcranial magnetic stimulation (rTMS) and the P50 evoked potential component in depression and s…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study [Phase 2, Phase 3]
A randomized controlled study evaluated high-frequency repetitive transcranial magnetic stimulation for auditory hallucinations in schizophr…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia [NA]
A clinical trial evaluating low-intensity focused ultrasound neuromodulation of the mediodorsal thalamus for treatment-resistant schizophren…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Ocrelizumab for Psychosis by Autoimmunity [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ocrelizumab as a treatment for autoimmune-related psychosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Evaluate the Effect of KarXT on Urological Safety [Phase 4]
Phase 4 trial update examining the effect of KarXT on urological safety in people with schizophrenia; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum [NA]
A completed clinical trial examining social cognition in adolescents with schizophrenia or autism spectrum disorder.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Online Intervention To Improve Motivation [NA]
An online intervention to improve motivation for individuals at risk for schizophrenia and related psychosis is listed as not yet recruiting…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia [NA]
A clinical trial investigating how brain stimulation affects cognition, neural oscillations, and GABA levels in schizophrenia; recruitment i…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms [NA]
Completed clinical study evaluating theta-burst repetitive transcranial magnetic stimulation (rTMS) for improving negative symptoms and cogn…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Shared Decision Making for Antipsychotic Medications [NA]
A clinical trial update from the New York State Psychiatric Institute describes an ongoing study on shared decision making for antipsychotic…
-
FDA approval · 2026-03-27FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for haloperidol decanoate from NorthStar RxLLC under ANDA216730.
-
FDA approval · 2026-03-27FDA Approved: ASENAPINE — Supplemental Application (Sigmapharm Laboratories, LLC)
FDA approved a supplemental application for asenapine from Sigmapharm Laboratories, allowing a generic version of asenapine to be marketed. …
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: PET Scanning in Parkinson s Disease
This completed clinical trial evaluated the use of positron emission tomography (PET) scanning in Parkinson disease; schizophrenia is listed…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Alexithymia Intervention for Suicide [Phase 1]
Phase 1 trial of an alexithymia intervention for suicide risk was terminated.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization [NA]
This clinical trial update from Stanford University concerns incentives and adherence to long-acting injectable medications after involuntar…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Substance Misuse To Psychosis for Stimulants [Phase 2, Phase 3]
Clinical trial update from the University of Hong Kong covering stimulant use with stimulant-induced psychosis and related schizophrenia-spe…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis [NA]
A clinical trial recruiting to study language disorders and the interaction between memory capabilities and semantic skills in people with p…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively [Phase 3]
A Phase 3 clinical trial update describing long-term safety and tolerability assessments of KarXT and KarX-EC for schizophrenia and autism-r…
-
CLINICAL_TRIALS other · 2026-03-27Clinical Trial Update: Mindfulness-Based Yoga in Schizophrenia [NA]
A clinical trial evaluating mindfulness-based yoga for schizophrenia has completed.